Camp4 Therapeutics Corporation
CAMP
$5.31
$0.030.57%
Weiss Ratings | CAMP - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D- | |||
Reward Grade | E+ | |||
Rating Factors | CAMP - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Weak | |||
Efficiency Index | Very Weak | |||
Solvency Index | Weak | |||
Total Return Index | Very Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | CAMP - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | -- | |||
Price History | CAMP - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 18.26% | |||
30-Day Total Return | 6.84% | |||
60-Day Total Return | -40.20% | |||
90-Day Total Return | -50.83% | |||
Year to Date Total Return | 7.71% | |||
1-Year Total Return | -- | |||
2-Year Total Return | -- | |||
3-Year Total Return | -- | |||
5-Year Total Return | -- | |||
52-Week High % Change | -57.07% | |||
52-Week Low % Change | 50.86% | |||
Price | CAMP - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $12.30 | |||
52-Week Low Price | $3.50 | |||
52-Week Low Price (Date) | Jan 14, 2025 | |||
52-Week High Price (Date) | Oct 14, 2024 | |||
Valuation | CAMP - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 106.45M | |||
Enterprise Value | 275.71M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -76.75 | |||
Earnings Per Share Growth | -19.04% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | -- | |||
Price/Book (Q) | -0.03 | |||
Enterprise Value/Revenue (TTM) | -- | |||
Price | $5.31 | |||
Enterprise Value/EBITDA (TTM) | -7.30 | |||
Enterprise Value/EBIT | -7.06 | |||
Market Cap Category | Micro Cap | |||
Dividends and Shares | CAMP - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 557.40K | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | CAMP - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | (617) 651-8867 | |||
Address | One Kendall Square Cambridge, MA 02139 | |||
Website | www.camp4tx.com | |||
Country | United States | |||
Year Founded | 2015 | |||
Profitability | CAMP - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -- | |||
Profit Margin | -- | |||
Management Effectiveness | CAMP - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -- | |||
Return on Equity | -- | |||
Income Statement | CAMP - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | -- | |||
Total Revenue (TTM) | -- | |||
Revenue Per Share | -- | |||
Gross Profit (TTM) | -- | |||
EBITDA (TTM) | -- | |||
EBIT (TTM) | -- | |||
Net Income (TTM) | -- | |||
Net Income Avl. to Common (TTM) | -- | |||
Total Revenue Growth (Q YOY) | -- | |||
Earnings Growth (Q YOY) | -15.29% | |||
EPS Diluted (TTM) | -- | |||
EPS Diluted Growth (Q YOY) | 17.19% | |||
Balance Sheet | CAMP - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 2.53M | |||
Cash Per Share (Q) | $4.54 | |||
Total Current Assets (Q) | 5.50M | |||
Total Preferred Equity (Q) | 162.15 | |||
Total Equity (Q) | 3.17M | |||
Current Ratio (Q) | 0.465 | |||
Book Value Per Share (Q) | -$158.04 | |||
Total Assets (Q) | 21.36M | |||
Total Current Liabilities (Q) | 11.83M | |||
Total Debt (Q) | 9.64M | |||
Total Liabilities (Q) | 18.19M | |||
Total Common Equity (Q) | -158.98M | |||
Cash Flow | CAMP - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -- | |||
Cash from Financing (TTM) | -- | |||
Net Change in Cash (TTM) | -- | |||
Levered Free Cash Flow (TTM) | -- | |||
Cash from Operations (TTM) | -- | |||